Leadership

CanariaBio Announces Milestone achievement of 50% patient enrollment in its Phase III FLORA-5 clinical study of its lead product oregovomab in front-line advanced ovarian cancer treatment

Retrieved on: 
Thursday, June 30, 2022 - 4:57am

For this ongoing Phase-III study, the last Independent Data Safety Monitoring Board (IDSMB) meeting held in March 2022 identified no safety concerns and IDSMB recommended to continue the study without modifications.

Key Points: 
  • For this ongoing Phase-III study, the last Independent Data Safety Monitoring Board (IDSMB) meeting held in March 2022 identified no safety concerns and IDSMB recommended to continue the study without modifications.
  • Indirect immunization with oregovomab interacts with immune modulating properties of infused paclitaxel and carboplatin resulting in synergistic clinical benefit as observed in a phase 2 trial.
  • Clinical and translational results were published in Gynecology Oncology 2020 156:523-529) and Cancer Immunology and Immunotherapy 2020 69: 383-397, respectively.
  • CanariaBio Inc. is a Korean biopharmaceutical company focused on the development and commercialization of immunotherapies for cancer.

CanariaBio Announces Milestone achievement of 50% patient enrollment in its Phase III FLORA-5 clinical study of its lead product oregovomab in front-line advanced ovarian cancer treatment

Retrieved on: 
Thursday, June 30, 2022 - 3:40am

For this ongoing Phase-III study, the last Independent Data Safety Monitoring Board (IDSMB) meeting held in March 2022 identified no safety concerns and IDSMB recommended to continue the study without modifications.

Key Points: 
  • For this ongoing Phase-III study, the last Independent Data Safety Monitoring Board (IDSMB) meeting held in March 2022 identified no safety concerns and IDSMB recommended to continue the study without modifications.
  • Indirect immunization with oregovomab interacts with immune modulating properties of infused paclitaxel and carboplatin resulting in synergistic clinical benefit as observed in a phase 2 trial.
  • Clinical and translational results were published in Gynecology Oncology 2020 156:523-529) and Cancer Immunology and Immunotherapy 2020 69: 383-397, respectively.
  • CanariaBio Inc. is a Korean biopharmaceutical company focused on the development and commercialization of immunotherapies for cancer.

Samsung Begins Chip Production Using 3nm Process Technology with GAA Architecture

Retrieved on: 
Thursday, June 30, 2022 - 3:00am

Samsung Electronics Co., Ltd., the world leader in semiconductor technology, today announced that it has started initial production of its 3-nanometer (nm) process node applying Gate-All-Around (GAA) transistor architecture.

Key Points: 
  • Samsung Electronics Co., Ltd., the world leader in semiconductor technology, today announced that it has started initial production of its 3-nanometer (nm) process node applying Gate-All-Around (GAA) transistor architecture.
  • View the full release here: https://www.businesswire.com/news/home/20220629005894/en/
    Samsung Foundry's begins chip production with 3nm GAA architecture.
  • Samsungs proprietary technology utilizes nanosheets with wider channels, which allow higher performance and greater energy efficiency compared to GAA technologies using nanowires with narrower channels.
  • Utilizing the 3nm GAA technology, Samsung will be able to adjust the channel width of the nanosheet in order to optimize power usage and performance to meet various customer needs.

PropTech Unicorn PLACE Hires Chief Technology Officer and Chief Marketing Officer

Retrieved on: 
Thursday, June 30, 2022 - 12:00am

BELLINGHAM, Wash., June 29, 2022 /PRNewswire-PRWeb/ -- PLACE, the industry's only all-in-one technology and business services platform powering the top 20% of real estate agents regardless of brokerage, announced today the hiring of a Chief Technology Officer (CTO), Emiliano Delucia, and Chief Marketing Officer (CMO), Abby Powell. Both Delucia and Powell have extensive backgrounds in technology product development and B2C marketing strategy, respectively. The two will play a pivotal role in scaling PLACE's already successful real estate technology and business services platform and its suite of real estate technology products, including Brivity.

Key Points: 
  • BELLINGHAM, Wash., June 29, 2022 /PRNewswire-PRWeb/ -- PLACE, the industry's only all-in-one technology and business services platform powering the top 20% of real estate agents regardless of brokerage, announced today the hiring of a Chief Technology Officer (CTO), Emiliano Delucia, and Chief Marketing Officer (CMO), Abby Powell.
  • Both Delucia and Powell have extensive backgrounds in technology product development and B2C marketing strategy, respectively.
  • This is exactly what PLACE needs to further our vision of becoming 'the' technology platform for agents and consumers alike," PLACE Co-Founder Ben Kinney said.
  • "Partnering with Emiliano and Abby is a win for the entire PLACE family," said PLACE Co-Founder Chris Saurez.

Israel Honors Pfizer CEO Albert Bourla with the "Jewish Nobel" Prize

Retrieved on: 
Wednesday, June 29, 2022 - 11:22pm

JERUSALEM, June 29, 2022 /PRNewswire/ -- Today the President of Israel Isaac Herzog presented the Genesis Prize to Dr. Albert Bourla at a ceremony in Israel's capital Jerusalem.

Key Points: 
  • The annual $1 million Genesis Prize, dubbed the "Jewish Nobel" by TIME magazine, honors extraordinary individuals for their outstanding professional achievement, contribution to humanity, commitment to Jewish values and the State of Israel.
  • Dr. Albert Bourla was announced as the 9th Genesis Prize Laureate in January 2022.
  • The President of Israel Isaac Herzog said: "Albert Bourla was not deterred by high stakes, by naysayers, by conspiracy or by politics.
  • 2022 Genesis Prize Laureate Dr. Albert Bourla said: "I am honored and deeply humbled to receive the Genesis Prize.

Israel Honors Pfizer CEO Albert Bourla with the "Jewish Nobel" Prize

Retrieved on: 
Wednesday, June 29, 2022 - 11:09pm

JERUSALEM, June 29, 2022 /PRNewswire/ -- Today the President of Israel Isaac Herzog presented the Genesis Prize to Dr. Albert Bourla at a ceremony in Israel's capital Jerusalem.

Key Points: 
  • The annual $1 million Genesis Prize, dubbed the "Jewish Nobel" by TIME magazine, honors extraordinary individuals for their outstanding professional achievement, contribution to humanity, commitment to Jewish values and the State of Israel.
  • Dr. Albert Bourla was announced as the 9th Genesis Prize Laureate in January 2022.
  • The President of Israel Isaac Herzog said: "Albert Bourla was not deterred by high stakes, by naysayers, by conspiracy or by politics.
  • 2022 Genesis Prize Laureate Dr. Albert Bourla said: "I am honored and deeply humbled to receive the Genesis Prize.

PDC Energy Announces Approval of Broe Oil and Gas Development Plan Permit Adding to Existing Multi-Year Inventory of Colorado Development Drilling Locations

Retrieved on: 
Wednesday, June 29, 2022 - 10:37pm

DENVER, June 29, 2022 (GLOBE NEWSWIRE) -- PDC Energy, Inc. (PDC or the Company) (Nasdaq: PDCE) announced today that the Colorado Oil and Gas Conservation Commission (COGCC) approved the Companys Broe Oil & Gas Development Plan (OGDP) permit, which encompasses 30 wells in rural Weld County, Colorado.

Key Points: 
  • DENVER, June 29, 2022 (GLOBE NEWSWIRE) -- PDC Energy, Inc. (PDC or the Company) (Nasdaq: PDCE) announced today that the Colorado Oil and Gas Conservation Commission (COGCC) approved the Companys Broe Oil & Gas Development Plan (OGDP) permit, which encompasses 30 wells in rural Weld County, Colorado.
  • The Broe OGDP was initiated by Great Western Petroleum, LLC (Great Western), which was acquired by PDC in May 2022, and represents PDCs first OGDP approval on Great Western acreage.
  • Broe is the second PDC OGDP to receive unanimous approval this month, and third approval within the last 12 months.
  • Our integration of the Great Western assets continues to go well as is evident from this approval.

WHEATON PRECIOUS METALS RECOGNIZED IN CORPORATE KNIGHTS' 2022 LIST OF THE BEST 50 CORPORATE CITIZENS IN CANADA

Retrieved on: 
Wednesday, June 29, 2022 - 10:00pm

TSX | NYSE | LSE: WPM

Key Points: 
  • TSX | NYSE | LSE: WPM
    VANCOUVER, BC, June 29, 2022 /PRNewswire/ - Wheaton Precious Metals Corp. ("Wheaton" or the "Company") is pleased to announce that it has been named to the Corporate Knights' 2022 list of the Best 50 Corporate Citizens in Canada.
  • "We are honoured that our ESG efforts have been recognized in this year's list of the Best 50 Corporate Citizens in Canada."
  • Corporate Knights, a Canadian media and research company has been producing global corporate and fund rankings for 20 years.
  • Wheaton recently published its third annual Sustainability Report highlighting the Company's Environmental, Social and Governance (ESG) performance and continued leadership.

Denver Regional Director Kurt L. Gottschall to Leave SEC

Retrieved on: 
Wednesday, June 29, 2022 - 7:32pm

Kurt has been an incredible leader of the Denver Regional Office, said Richard R. Best, Director of the Division of Examinations.

Key Points: 
  • Kurt has been an incredible leader of the Denver Regional Office, said Richard R. Best, Director of the Division of Examinations.
  • It has been an incredible honor and privilege to serve as the Director of the Denver office, said Mr. Gottschall.
  • As Regional Director, Mr. Gottschall oversaw all examinations, investigations, and enforcement litigation across the Denver Regional Offices eight-state region.
  • Earlier in his SEC tenure, he served in the Asset Management Unit as an Assistant Director and then Associate Regional Director for Enforcement in the Denver office.

Tracy S. Combs Named Director of SEC's Salt Lake Regional Office

Retrieved on: 
Wednesday, June 29, 2022 - 7:11pm

Washington, D.C.--(Newsfile Corp. - June 29, 2022) - The Securities and Exchange Commission today announced that Tracy S. Combs has been named Director of the Salt Lake Regional Office.

Key Points: 
  • Washington, D.C.--(Newsfile Corp. - June 29, 2022) - The Securities and Exchange Commission today announced that Tracy S. Combs has been named Director of the Salt Lake Regional Office.
  • Id like to thank Tanya for stepping in as Acting Director and guiding the Salt Lake Regional Office through the recent transition period.
  • I am pleased that Tracy will take on the important role of leading the talented and dedicated staff of the Salt Lake Regional Office, said Gurbir Grewal, Director of the SECs Division of Enforcement.
  • Since September 2020, Ms. Combs has served as both a staff and trial attorney in the Salt Lake Regional Office.